Clonal Hematopoiesis Is Associated With Long‐Term Adverse Outcomes Following Cardiac Surgery
Year: 2024
Type: article
Study design: Observational Study
Abstract: Background Cardiac surgery triggers sterile innate immune responses leading to postoperative complications. Clonal hematopoiesis (CH) is associated with short‐term inflammation‐mediated outcomes after cardiac surgery. The impact of CH on long‐term postoperative outcomes remains unknown. Methods and Results In this cohort study, patients undergoing elective cardiac surgery were included from January 2017 to September 2019. Patients were screened for CH using a predefined gene panel of 19 genes. Recorded clinical events were all‐cause death, major adverse cardiac and cerebral events including cardiovascular death, myocardial infarction or nonscheduled coronary revascularization, stroke, and hospitalization for acute heart failure. The primary study outcome was time to a composite criterion including all‐cause mortality and major adverse cardiac and cerebral events. Among 314 genotyped patients (median age: 67 years; interquartile range 59–74 years), 139 (44%) presented with CH, based on a variant allelic frequency ≥1%. Carriers of CH had a higher proportion of patients with a history of atrial fibrillation (26% for CH versus 17% for non‐CH carriers, P =0.022). The most frequently mutated genes were DNMT3A , TET2 , and ASXL1 . After a median follow‐up of 1203 [813–1435] days, the primary outcome occurred in 50 patients. After multivariable adjustment, CH was independently associated with a higher risk for the primary outcome (hazard ratio, 1.88 [95% CI, 1.05–3.41], P =0.035). Most adverse events occurred in patients carrying TET2 variants. Conclusions In patients undergoing cardiac surgery, CH is frequent and associated with a 2‐fold increased long‐term risk for major adverse clinical outcomes. CH is a novel risk factor for long‐term postcardiac surgery complications and might be useful to personalize management decisions. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03376165.
Authors: Sandro Ninni, Rocio Vicario, Augustin Coisne, Eloise Woitrain, Amine Tazibet, Caitlin M. Stewart, Luis A. Diaz, James Robert White, Mohammed Koussa, Henri Dubrulle, Francis Juthier, Marie Jungling, André Vincentelli, Jean‐Louis Edme, Stanley Nattel, Menno de Winther, Frederic Geissmann, David Dombrowicz, Bart Staels, David Montaigne
Institutions: Inserm, Université de Lille, Montreal Heart Institute, Institut Pasteur de Lille, Centre Hospitalier Universitaire de Lille, Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires, Université de Montréal, Memorial Sloan Kettering Cancer Center, Resphera Biosciences, IMPact de l'Environnement Chimique sur la Santé, Amsterdam University Medical Centers, Amsterdam Cardiovascular Sciences
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,700
Funders: American Association for Cancer Research, Memorial Sloan-Kettering Cancer Center, Agence Nationale de la Recherche, Fondation Leducq, Fondation pour la Recherche Médicale, Fédération Française de Cardiologie, National Institutes of Health, Stand Up To Cancer, Ludwig Center at Harvard, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke
Awards: Lineages and pathophysiology of clonal histiocytic disorders, Role of Microglia Somatic Variants in Neurodegenerative Diseases, EGID Diabetes Pole, Clinical Scholars Biomedical Research Training Program, Cancer Center Support Grant, Development of the resident macrophage lineage in mouse and human
OpenAlex ID: W4402005151
